Automatic brain segmentation in cognitive impairment: Validation of AI-based AQUA software in the Southeast Asian BIOCIS cohort.
10.47102/annals-acadmedsg.2024317
- Author:
Ashwati VIPIN
1
;
Rasyiqah BINTE SHAIK MOHAMED SALIM
1
;
Regina Ey KIM
2
;
Minho LEE
2
;
Hye Weon KIM
2
;
ZunHyan RIEU
2
;
Nagaendran KANDIAH
1
Author Information
1. Dementia Research Centre (Singapore), Lee Kong Chian School of Medicine, Nanyang Technology University, Singapore.
2. Research Institute, Neurophet Inc., Seoul, Republic of Korea.
- Publication Type:Validation Study
- Keywords:
artificial intelligence;
automated brain segmentation;
brain imaging;
dementia
- MeSH:
Humans;
Cognitive Dysfunction/pathology*;
Magnetic Resonance Imaging/methods*;
Male;
Middle Aged;
Female;
Aged;
Artificial Intelligence;
Software;
Dementia/diagnostic imaging*;
Aged, 80 and over;
Adult;
Singapore;
Neuropsychological Tests;
Brain/pathology*;
Cohort Studies;
Gray Matter/pathology*;
Southeast Asian People
- From:Annals of the Academy of Medicine, Singapore
2025;54(8):467-475
- CountrySingapore
- Language:English
-
Abstract:
INTRODUCTION:Interpretation and analysis of magnetic resonance imaging (MRI) scans in clinical settings comprise time-consuming visual ratings and complex neuroimage processing that require trained professionals. To combat these challenges, artificial intelligence (AI) techniques can aid clinicians in interpreting brain MRI for accurate diagnosis of neurodegenerative diseases but they require extensive validation. Thus, the aim of this study was to validate the use of AI-based AQUA (Neurophet Inc., Seoul, Republic of Korea) segmentation software in a Southeast Asian community-based cohort with normal cognition, mild cognitive impairment (MCI) and dementia.
METHOD:Study participants belonged to the community-based Biomarker and Cognition Study in Singapore. Participants aged between 30 and 95 years, having cognitive concerns, with no diagnosis of major psychiatric, neurological or systemic disorders who were recruited consecutively between April 2022 and July 2023 were included. Participants underwent neuropsychological assessments and structural MRI, and were classified as cognitively normal, with MCI or with dementia. MRI pre-processing using automated pipelines, along with human-based visual ratings, were compared against AI-based automated AQUA output. Default mode network grey matter (GM) volumes were compared between cognitively normal, MCI and dementia groups.
RESULTS:A total of 90 participants (mean age at visit was 63.32±10.96 years) were included in the study (30 cognitively normal, 40 MCI and 20 dementia). Non-parametric Spearman correlation analysis indicated that AQUA-based and human-based visual ratings were correlated with total (ρ=0.66; P<0.0001), periventricular (ρ=0.50; P<0.0001) and deep (ρ=0.57; P<0.0001) white matter hyperintensities (WMH). Additionally, volumetric WMH obtained from AQUA and automated pipelines was also strongly correlated (ρ=0.84; P<0.0001) and these correlations remained after controlling for age at visit, sex and diagnosis. Linear regression analyses illustrated significantly different AQUA-derived default mode network GM volumes between cognitively normal, MCI and dementia groups. Dementia participants had significant atrophy in the posterior cingulate cortex compared to cognitively normal participants (P=0.021; 95% confidence interval [CI] -1.25 to -0.08) and in the hippocampus compared to cognitively normal (P=0.0049; 95% CI -1.05 to -0.16) and MCI participants (P=0.0036; 95% CI -1.02 to -0.17).
CONCLUSION:Our findings demonstrate high concordance between human-based visual ratings and AQUA-based ratings of WMH. Additionally, the AQUA GM segmentation pipeline showed good differentiation in key regions between cognitively normal, MCI and dementia participants. Based on these findings, the automated AQUA software could aid clinicians in examining MRI scans of patients with cognitive impairment.
